Obesity, Morbid |
Phase 4 |
ClinicalTrials |
Malabsorption Syndromes |
Phase 4 |
ClinicalTrials |
Crohn Disease; Malabsorption Syndromes |
Phase 4 |
ClinicalTrials |
Diabetes Mellitus; Diabetes Mellitus, Type 2 |
Phase 3 |
ClinicalTrials |
Glucose Intolerance; Insulin Resistance; Prediabetic State |
Phase 3 |
ClinicalTrials |
Obesity, Morbid |
Phase 4 |
ClinicalTrials |
Fecal Incontinence; Malabsorption Syndromes |
Phase 3 |
ClinicalTrials |
Diarrhea; Irritable Bowel Syndrome; Syndrome |
Phase 2 |
ClinicalTrials |
Diabetes Mellitus, Type 2 |
Phase 4 |
ClinicalTrials |
Diarrhea; Multiple Myeloma; Neoplasms, Plasma Cell |
Phase 2 |
ClinicalTrials |
Diabetes Mellitus; Diabetes Mellitus, Type 2 |
Phase 2 |
ClinicalTrials |
Dyslipidemias; Hyperglycemia; Hyperlipidemias; Hyperlipoproteinemias |
Phase 4 |
ClinicalTrials |
Liver Diseases; Pruritus |
Phase 2/Phase 3 |
ClinicalTrials |
Diabetes Mellitus, Type 2 |
Phase 4 |
ClinicalTrials |
Diarrhea; Irritable Bowel Syndrome; Malabsorption Syndromes |
Phase 2 |
ClinicalTrials |
Diarrhea; Irritable Bowel Syndrome; Syndrome |
Phase 4 |
ClinicalTrials |
Atherosclerosis; Carotid Artery Diseases; Coronary Artery Disease |
Phase 4 |
ClinicalTrials |
Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Intolerance; Hypercholesterolemia; Prediabetic State |
Phase 3 |
ClinicalTrials |